Piotr Niedziejko

Title: Piotr Niedziejko: Innovator in Therapeutic Compounds

Introduction

Piotr Niedziejko is a prominent inventor based in Warsaw, Poland. He has made significant contributions to the field of therapeutic compounds, particularly in the development of inhibitors that target specific biological activities. With a total of 2 patents, his work is paving the way for innovative treatments in various medical conditions.

Latest Patents

Niedziejko's latest patents include groundbreaking inventions. The first patent focuses on deubiquitinase inhibitors and methods of use thereof. The inventive compounds are small molecule therapeutics that are potent inhibitors of USP7 activity. This invention also provides pharmaceutical compositions comprising the compounds, along with methods for using them to treat or prevent diseases associated with USP7 activity. The second patent involves substituted amino triazoles useful as chitinase inhibitors. This patent discloses amino triazole compounds that inhibit acidic mammalian chitinase and chitotriosidase. The methods outlined in this patent aim to treat asthma reactions caused by allergens, as well as various inflammatory, autoimmune, dental, neurologic, metabolic, liver diseases, polycystic ovary syndrome, endometriosis, and cancer.

Career Highlights

Niedziejko is currently associated with Molecure S.A., a company dedicated to developing innovative therapies. His work at Molecure has been instrumental in advancing research and development in the pharmaceutical industry.

Collaborations

He collaborates with talented professionals, including Marzena Mazur and Sylwia Olejniczak, who contribute to the innovative environment at Molecure.

Conclusion

Piotr Niedziejko's contributions to the field of therapeutic compounds highlight his role as a key innovator. His patents reflect a commitment to addressing significant medical challenges through innovative solutions.